Trial intelligence / Profile preview

L-carnitine with clomiphene citrate in infertile women with polycystic ovary syndrome

IRCT20211204053267N1Phase 3Completed

Sponsor
Tarbiat Modares University
Start
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of levocarnitine in female infertility and polycystic ovary syndrome (PCOS), sponsored by Tarbiat Modares University. Primary endpoints: Ovulation rate and Conception rate. Started Jan 2022; status: completed.

02

Drugs

levocarnitine
03

Conditions

female infertilitypolycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on IRCT20211204053267N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211204053267N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call